Distinct composition and metabolic functions of human gut microbiota are associated with cachexia in lung cancer patients
Cachexia is associated with decreased survival in cancer patients and has a prevalence of
up to 80%. The etiology of cachexia is poorly understood, and limited treatment options exist. …
up to 80%. The etiology of cachexia is poorly understood, and limited treatment options exist. …
The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas
J Moldvay, M Jackel, K Bogos, I Soltész… - Pathology & Oncology …, 2004 - Springer
Thyroid transcription factor-1 (TTF-1) is a sensitive marker for pulmonary and thyroid
adenocarcinomas. The aim of this work was to determine its usefulness in distinction between …
adenocarcinomas. The aim of this work was to determine its usefulness in distinction between …
Afatinib restrains K-RAS–driven lung tumorigenesis
…, D Schramek, R Moriggl, R Eferl, J Moldvay… - Science translational …, 2018 - science.org
On the basis of clinical trials using first-generation epidermal growth factor receptor (EGFR)
tyrosine kinase inhibitors (TKIs), it became a doctrine that V-Ki-ras2 Kirsten rat sarcoma viral …
tyrosine kinase inhibitors (TKIs), it became a doctrine that V-Ki-ras2 Kirsten rat sarcoma viral …
Expression patterns and prognostic relevance of subtype‐specific transcription factors in surgically resected small‐cell lung cancer: an international multicenter study
…, J Fillinger, Z Lohinai, J Moldvay… - The Journal of …, 2022 - Wiley Online Library
The tissue distribution and prognostic relevance of subtype‐specific proteins (ASCL1,
NEUROD1, POU2F3, YAP1) present an evolving area of research in small‐cell lung cancer (SCLC…
NEUROD1, POU2F3, YAP1) present an evolving area of research in small‐cell lung cancer (SCLC…
Breast carcinoma subtypes show different patterns of metastatic behavior
…, J Tamás, P Deák, C Szundi, B Székely, J Moldvay… - Virchows Archiv, 2017 - Springer
The aim of our retrospective study was to analyze patterns of subtype specific metastatic
spread and to identify the time course of distant metastases. A consecutive series of 490 …
spread and to identify the time course of distant metastases. A consecutive series of 490 …
[HTML][HTML] KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone …
Z Lohinai, T Klikovits, J Moldvay, G Ostoros, E Raso… - Scientific reports, 2017 - nature.com
Current guidelines lack comprehensive information on the metastatic site-specific role of
KRAS mutation in lung adenocarcinoma (LADC). We investigated the effect of KRAS mutation …
KRAS mutation in lung adenocarcinoma (LADC). We investigated the effect of KRAS mutation …
A clonal expression biomarker associates with lung cancer mortality
…, S Veeriah, GA Wilson, M Jamal-Hanjani, J Moldvay… - Nature medicine, 2019 - nature.com
An aim of molecular biomarkers is to stratify patients with cancer into disease subtypes
predictive of outcome, improving diagnostic precision beyond clinical descriptors such as tumor …
predictive of outcome, improving diagnostic precision beyond clinical descriptors such as tumor …
Neuroendocrine subtypes of small cell lung cancer differ in terms of immune microenvironment and checkpoint molecule distribution
…, T Harko, Z Megyesfalvi, J Moldvay… - Molecular …, 2020 - Wiley Online Library
Small cell lung cancer (SCLC) has recently been subcategorized into neuroendocrine (NE)‐high
and NE‐low subtypes showing ‘immune desert’ and ‘immune oasis’ phenotypes, …
and NE‐low subtypes showing ‘immune desert’ and ‘immune oasis’ phenotypes, …
[HTML][HTML] Subtype-specific KRAS mutations in advanced lung adenocarcinoma: a retrospective study of patients treated with platinum-based chemotherapy
…, E Raso, T Barbai, J Timar, A Rozsas, J Moldvay… - European journal of …, 2014 - Elsevier
Background Platinum-based chemotherapy is the most common treatment in advanced-stage
lung adenocarcinoma. Because the clinical significance of KRAS mutational status in this …
lung adenocarcinoma. Because the clinical significance of KRAS mutational status in this …
[HTML][HTML] Distinct epidemiology and clinical consequence of classic versus rare EGFR mutations in lung adenocarcinoma
…, M Grusch, W Berger, W Klepetko, J Moldvay… - Journal of thoracic …, 2015 - Elsevier
Introduction Although classic sensitizing mutations of epidermal growth factor receptor (EGFR)
are positive predictive markers for EGFR tyrosine kinase inhibitors (TKIs) in lung …
are positive predictive markers for EGFR tyrosine kinase inhibitors (TKIs) in lung …
